🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jennifer Sims‐Mourtada

Christiana Care Health System

ORCID: 0000-0003-1602-4560
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile
1.8Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Racial disparities in triple negative breast cancer: toward a causal architecture approach

Breast Cancer Research(2022)10.1186/s13058-022-01533-z
Top 12%
1.8DataRank
Top 12%40 citations

Madeline M. Brooks, Shannon M. Lynch, Jennifer Sims‐Mourtada, Zachary T. Schug, Frank C. Curriero +1 more

Papers

Driven by 8 papers — median percentile 88. Top paper: “Racial disparities in triple negative breast cancer: toward a causal architecture approach”.

Racial disparities in triple negative breast cancer: toward a causal architecture approach

Breast Cancer Research(2022)10.1186/s13058-022-01533-z
Top 12%
1.8DataRank
Top 12%40 citations

Madeline M. Brooks, Shannon M. Lynch, Jennifer Sims‐Mourtada, Zachary T. Schug, Frank C. Curriero +1 more

Mutant p53 binds and controls estrogen receptor activity to drive endocrine resistance in ovarian cancer

Genes & Development(2025)10.1101/gad.352953.125
N/A
0.171DataRank · unranked
2 citations

Alexandra Indeglia, Maya Foster, Kaitlyn Casey, Jessica C. Leung, Shirin Modarai +10 more

Tumor-B-cell Interactions Promote Isotype Switching to an Immunosuppressive IgG4 Antibody Response Through Upregulation of IL-10 in Triple Negative Breast Cancers

Research Square(2021)10.21203/rs.3.rs-956230/v2
N/A
0DataRank · unranked
1 citations

Lynn M. Opdenaker, Kader Cicek, Lisa Frerichs, Christopher Ryan Kennington, Samuel Oberly +4 more

Tumor-B-Cell Interactions Promote Isotype Switching to an Immunosuppressive IgG4 Antibody Response Through Upregulation of IL-10 in Triple Negative Breast Cancers

Research Square(2021)10.21203/rs.3.rs-956230/v1
N/A
0DataRank · unranked
0 citations

Lynn M. Opdenaker, Kader Cicek, Holly Archinal, Lisa Frerichs, Christopher Ryan Kennington +4 more

Racial Disparities in Triple Negative Breast Cancer: Toward a Causal Architecture Approach

Research Square(2021)10.21203/rs.3.rs-1177963/v1
N/A
0DataRank · unranked
2 citations

Madeline M. Brooks, Shannon M. Lynch, Jennifer Sims‐Mourtada, Zachary T. Schug, Frank C. Curriero +1 more

Tumor-B-cell interactions promote isotype switching to an immunosuppressive IgG4 antibody response through upregulation of IL-10 in triple negative breast cancers

Journal of Translational Medicine(2022)10.1186/s12967-022-03319-5
N/A
0DataRank · unranked
26 citations

Lynn M. Opdenaker, Kader Cicek, Lisa Frerichs, Christopher Ryan Kennington, Samuel Oberly +4 more

B cells enhance IL-1 beta driven invasiveness in triple negative breast cancer

Scientific Reports(2025)10.1038/s41598-025-86064-1
N/A
0DataRank · unranked
12 citations

Lynn M. Opdenaker, Lisa Frerichs, Shirin Modarai, Aihui Ma, Holly Archinal +3 more

Fatty acid synthase as a feasible biomarker for triple negative breast cancer stem cell subpopulation cultured on electrospun scaffolds

Materials Today Bio(2021)10.1016/j.mtbio.2021.100155
N/A
0DataRank · unranked
18 citations

Emma Polonio‐Alcalá, Joana Relat, Marc Yeste, Jennifer Sims‐Mourtada, April M. Kloxin +5 more